---
schema_version: "secwatch.filing_event.v1"
accession: "0001285550-24-000107"
form_type: "8-K"
ticker: "CLPT"
cik: "0001285550"
company_name: "ClearPoint Neuro, Inc."
filed_at: "2024-08-26T23:59:59+00:00"
generated_at: "2026-05-31T07:35:35.211230+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ClearPoint Neuro repays $10M convertible note early, eliminates all debt

## Summary
- On Aug 23, 2024, fully repaid $10M convertible note held by PTC Therapeutics (orig. maturity Jan 2025).
- Note was issued in Jan 2020; early repayment removes all debt from ClearPoint's balance sheet.
- CEO says repayment avoids additional dilution and reflects confidence in the business.
- PTC continues to support ClearPoint for Upstaza BLA submission to FDA for AADC deficiency.

## SEC filing metadata
- accession: 0001285550-24-000107
- form_type: 8-K
- ticker: CLPT
- cik: 0001285550
- company_name: ClearPoint Neuro, Inc.
- filed_at: 2024-08-26T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000107/0001285550-24-000107-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000107/clpt-20240826.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001285550-24-000107
- JSON: https://secwatch.observer/filing/0001285550-24-000107.json
- Plain text: https://secwatch.observer/filing/0001285550-24-000107.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.